custom t shirt front pocket

custom t shirt campaign

Oct 04, 2018

Hemp Oil Brands

GW Pharmaceuticals plc (Nasdaq:GWPH) (GW, the Company or the Group), a biopharmaceutical enterprise focused on discovering, establishing and commercializing novel therapeutics from its proprietary cannabinoid product platform, right now announced that the European Medicines Agency (EMA) has granted orphan drug designation for cannabidiol (CBD) for the therapy of tuberous sclerosis (TS) GW is presently recruiting a Phase 3 clinical trial of Epidiolex (cannabidiol) as an adjunctive therapy for the treatment of seizures connected with TS, with information expected in the second half of 2018.My